Geron Corp (GERN) stock
GERNNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.00+0.06 (+6.17%)
Close on Nov 17, 2026Market cap $642.47MP/E –Yield –
Geron profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Geron's profit margin for the twelve months ending Sep 30, 2024 was -682.5%. For fiscal 2023 it was -77690.7%, against -23808.9% the year before. The highest annual figure on record is 0.1% in fiscal 2015.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | -77690.7% | −53881.8 |
| FY2022 | Dec 31, 2022 | -23808.9% | −15473.5 |
| FY2021 | Dec 31, 2021 | -8335.4% | +21552.8 |
| FY2020 | Dec 31, 2020 | -29888.1% | −14986.4 |
| FY2019 | Dec 31, 2019 | -14901.7% | −12367.3 |
| FY2018 | Dec 31, 2018 | -2534.4% | +86.8 |
| FY2017 | Dec 31, 2017 | -2621.2% | −2141.9 |
| FY2016 | Dec 31, 2016 | -479.3% | −479.5 |
| FY2015 | Dec 31, 2015 | 0.1% | +3093.8 |
| FY2014 | Dec 31, 2014 | -3093.7% | −102.3 |
| FY2013 | Dec 31, 2013 | -2991.3% | −448.7 |
| FY2012 | Dec 31, 2012 | -2542.7% | +1430.0 |
| FY2011 | Dec 31, 2011 | -3972.6% | −846.7 |
| FY2010 | Dec 31, 2010 | -3125.9% | +940.3 |
| FY2009 | Dec 31, 2009 | -4066.3% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -29.0% | +21.1 |
| Q1 FY2026 | Mar 31, 2026 | -7.0% | +86.5 |
| Q3 FY2025 | Sep 30, 2025 | -39.0% | +7600.8 |
| Q2 FY2025 | Jun 30, 2025 | -33.4% | +18187.0 |
| Q1 FY2025 | Mar 31, 2025 | -50.1% | +225919.5 |
| Q3 FY2024 | Sep 30, 2024 | -93.5% | +27226.6 |
| Q2 FY2024 | Jun 30, 2024 | -7639.8% | +162108.5 |
| Q1 FY2024 | Mar 31, 2024 | -18220.4% | +163312.9 |
| Q4 FY2023 | Dec 31, 2023 | -225969.6% | −184576.4 |
| Q3 FY2023 | Sep 30, 2023 | -27320.1% | −13498.2 |
| Q2 FY2023 | Jun 30, 2023 | -169748.3% | −131231.8 |
| Q1 FY2023 | Mar 31, 2023 | -181533.3% | −157063.4 |
| Q4 FY2022 | Dec 31, 2022 | -41393.2% | −38314.6 |
| Q3 FY2022 | Sep 30, 2022 | -13821.9% | +10670.8 |
| Q2 FY2022 | Jun 30, 2022 | -38516.4% | −10877.2 |
| Q1 FY2022 | Mar 31, 2022 | -24469.9% | −4160.4 |
| Q4 FY2021 | Dec 31, 2021 | -3078.6% | +44495.4 |
| Q3 FY2021 | Sep 30, 2021 | -24492.7% | −6297.3 |
| Q2 FY2021 | Jun 30, 2021 | -27639.3% | +9160.7 |
| Q1 FY2021 | Mar 31, 2021 | -20309.5% | +11142.4 |
| Q4 FY2020 | Dec 31, 2020 | -47574.0% | −30574.0 |
| Q3 FY2020 | Sep 30, 2020 | -18195.4% | −6607.6 |
| Q2 FY2020 | Jun 30, 2020 | -36800.0% | −22702.0 |
| Q1 FY2020 | Mar 31, 2020 | -31451.9% | −13804.6 |
| Q4 FY2019 | Dec 31, 2019 | -17000.0% | −15053.3 |
| Q3 FY2019 | Sep 30, 2019 | -11587.8% | −8195.7 |
| Q2 FY2019 | Jun 30, 2019 | -14098.0% | −10764.4 |
| Q1 FY2019 | Mar 31, 2019 | -17647.4% | −15387.6 |
| Q4 FY2018 | Dec 31, 2018 | -1946.7% | +1942.9 |
| Q3 FY2018 | Sep 30, 2018 | -3392.1% | +840.4 |
| Q2 FY2018 | Jun 30, 2018 | -3333.7% | +347.4 |
| Q1 FY2018 | Mar 31, 2018 | -2259.7% | −922.1 |
| Q4 FY2017 | Dec 31, 2017 | -3889.5% | +5133.9 |
| Q3 FY2017 | Sep 30, 2017 | -4232.5% | −4162.5 |
| Q2 FY2017 | Jun 30, 2017 | -3681.0% | – |
| Q1 FY2017 | Mar 31, 2017 | -1337.6% | – |
| Q4 FY2016 | Dec 31, 2016 | -9023.4% | – |
| Q3 FY2016 | Sep 30, 2016 | -70.0% | – |
See a number that looks wrong?